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Abstract
Background: Sudomotor dysfunction is one of the earliest pathophysiologic abnormalities in diabetes. Su-
doscan (Impeto Medical, Paris, France) was developed as a noninvasive, rapid, and quantitative assessment of
sudomotor function and has been shown to be sensitive in the detection of neuropathy. This global collaborative
analysis aimed to establish reference values in healthy subjects of different ethnic groups, age, and gender, to
define factors potentially affecting results, and to provide standardization of the methodology.
Materials and Methods: Data from 1,350 generally healthy study participants who underwent sudomotor
function testing were collected and analyzed. The relationship between age, height, weight, gender, glycemic
and lipid profiles, ethnicity, and hand and foot electrochemical skin conductance (ESC) was assessed among
subgroups of participants.
Results: Lower mean hands and feet ESC values were observed in African American, Indian, and Chinese
subjects (P < 0.0001). No participant discomfort or safety concern was reported in 1,376 tests. No significant
difference in ESC was observed between women and men at the hands (75 [57–87] vs. 76 [56–89] lS; P = 0.35)
or feet (83.5 [71–90] vs. 82.5 [70–91] lS; P = 0.12). The coefficient of correlation between right and left side
ESC was r= 0.96, P< 0.0001 for hands and r= 0.97, P< 0.0001 for feet. A significant but weak correlation was
observed between ESC and age: for hands, r =-0.17, P< 0.0001; for feet, r= -0.19, P< 0.0001.
Conclusions: A normative reference range was established in whites showing that there was no effect of sex or
body mass index and a slight decrease in ESC with age. Ethnicity influenced ESC scores, but additional studies
are necessary to validate this effect and determine its mechanism and impact on nerve function.
Introduction
Changes in peripheral autonomic nervous systemfunction may be the earliest manifestation of distal
symmetric polyneuropathy with small fiber involvement,
occurring in many neurologic or metabolic diseases, in-
cluding diabetes.1 As eccrine sweat glands are innervated by
a rich supply of sympathetic C nerve fibers, sudomotor
function represents one of the best tests to evaluate the pe-
ripheral autonomic system.2,3 Several methods have been
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developed to evaluate the structure or function of sweat gland
innervation.4–6
Sudoscan (Impeto Medical, Paris, France) is a simple,
noninvasive, rapid, objective, and quantitative test recently
developed as an objective measure of small nerve fiber
function.7,8 The underlying technology is based on the elec-
trochemical reaction between the chloride ions in sweat and
stainless steel plate electrodes in contact with the palms and
soles where sweat gland density is the highest. Results are
provided as electrochemical skin conductance (ESC) gener-
ated from the derivative current associated with the stimulus
voltage. The method has been compared with reference
tests, and its diagnostic utility in the detection of diabetic
peripheral neuropathy has been validated in previous clinical
studies.6,9–11 However, small fiber or sweat function, when
assessed by other validated tools, has been shown to be
influenced in healthy subjects by factors such as age, gender,
race, or testing conditions, and there remains a need to define
normative reference values for this new technology.12,13
The aim of this analysis is to present normative ESC values
among 1,350 healthy subjects enrolled in multiple clinical
trials across the world and to explore factors potentially
influencing them, including age, sex, bodymass index (BMI),
blood pressure, glycemic and lipid parameters, and ethnicity.
Validation of the normative ESC derived from a primary
cohort was then conducted among (1) subgroups with precise
examination of the peripheral nervous system using reference
tests, (2) groups with glycemic, lipid, or renal profiles, and (3)
subjects measured before and after exercise.
Research Design and Methods
This global collaboration aimed to collect and analyze
data obtained in healthy subjects involved in clinical studies
performed in France, Finland, the United States, Mexico,
India, and China between 2009 and 2014. All study protocols
were approved by local ethics committees and institutional
review boards, and participants provided written informed
consent.
Study population
ESC results were obtained from a total of 1,350 partici-
pants, ages 21–80 years inclusive.
The effect of age, BMI, and sex was studied on a large
white population (termed the Primary Cohort) (n= 657) who
participated in studies completed in France and Finland.14–16
Eligibility criteria for inclusion as healthy subjects in the
analysis were age ‡18 years, BMI <25 kg/m2, and absence of
cardiovascular disease, symptoms of peripheral neuropathy,
or medical conditions known to cause neuropathy, including
diabetes, impaired glucose tolerance, or alcohol abuse.
Fasting plasma glucose or hemoglobin A1c was available in a
subgroup of 244 participants to confirm health status. Phys-
ical fitness was evaluated in a majority of participants with
estimated maximum volume of O2 of >7 metabolic equiva-
lents required for women and >9 metabolic equivalents for
men. Eighty-seven participants of this cohort, all age >70
years and part of the PROgnostic indicator OF cardiovascular
and cerebrovascular events (PROOF) study, underwent ad-
ditional assessments to exclude autonomic neuropathy,
metabolic syndrome, or sleep apnea.16 In this older subgroup,
criteria for defining health included sleep apnea–hypopnea
index of <30/h, spontaneous cardiac baroreflex activity slope
of ‡6mm Hg, minimal arterial O2 saturation value recorded
during sleep of ‡90%, oxygen desaturation index of <7.5 (n/
h), and body fat index (total body fat mass divided by the
squared height in meters) of <9.3 kg/m2.
Healthy control participants (n= 142) recruited in three
U.S. research centers underwent concurrent evaluation of
peripheral nerve function with questionnaires (the Michigan
Neuropathy Screening Instrument), structured examination
(total neuropathy score, Neuropathy Impairment Score Lower
Limbs), tests of small-diameter nociceptive function (quan-
titative sensory testing for heat pain threshold), or car-
diac autonomic reflex testing. Similarly, data from 525
healthy control participants enrolled in four previously pub-
lished studies10,17–19 were extracted to examine the effect of
FIG. 1. Correlation between right and left sides for (a)
hand and (b) foot electrochemical skin conductance (ESC)
values.
392 VINIK ET AL.
D
ow
nl
oa
de
d 
by
 U
ni
ve
rs
ity
 o
f M
ic
hi
ga
n 
e-
jou
rna
l p
ack
ag
e f
rom
 on
lin
e.l
ieb
ert
pu
b.c
om
 at
 12
/11
/17
. F
or 
pe
rso
na
l u
se 
on
ly.
 
race/ethnicity on ESC results. These participants underwent
extensive metabolic testing (glycemic, lipid, and/or renal
profiles with measurement of estimated glomerular filtration
rate using the Modification of Diet in Renal Disease formu-
lation). ESC results from well-characterized Mexican sub-
jects (normal glycemic and lipid profiles; no chronic illness,
cancer, or pregnancy) were used to explore the effect of
Hispanic ethnicity.17 The effect of race on ESC values was
studied in groups of healthy African American (n= 117),
Indian (n= 96), and Chinese (n = 120) subjects in comparison
with the white population (of comparable age) precisely de-
scribed in previous publications.10,18,19
Sudomotor function assessment
Sudoscan is a patented device designed to perform a pre-
cise quantitative evaluation of sweat gland function based
on an electrochemical reaction with sweat chloride ions
using reverse iontophoresis and chronoamperometry.20,21
Neither special subject preparation nor specially trained
medical personnel are required to complete the test. The
apparatus consists of two sets of stainless steel electrodes
connected to a computer for recording and data manage-
ment purposes. To conduct the test, the individual places his
or her palms and soles—where sweat gland density is
highest—in contact with the electrodes during a 2-min
testing period. The sweat chloride ions attracted when low
direct current (incremental voltages £4V) is applied create a
current through an electrochemical reaction with the nickel
incorporated in the electrodes. ESC (i.e., the ratio between
chloride-specific current generated and the voltage of con-
stant direct current stimulus) is displayed immediately after
the test in units of microSiemens (lS), with separate results
for hands and feet.
To confirm that the conductance measurements are inde-
pendent of the subject’s sweating status, a comparison was
done between a first ESC measurement performed at rest and
a second performed under identical conditions immediately
following a bicycle ergometer graded exercise test used to
reach maximum volume of O2 uptake (n = 26).15
Statistical analyses
A blinded analysis of the data was performed by an inde-
pendent statistician. Results for quantitative variables are
shown as mean – SD values or median and 5th–95th percentile
intervals. Student’s t test was used for significant differences
between means, and Mood’s test was used for medians
to detect differences in gender and ethnicity. In the small
subgroup of participants who were exercised, we compared
hands and feet ESC values before and after exercise using the
Wilcoxon signed-rank test. Pearson’s correlation coefficient
was used to evaluate the association between hand/foot ESC,
age, and BMI, as well as the correlation between hand/foot
conductance on the left and right sides. Multiple linear re-
gression analyses were performed with foot ESCs as depen-
dent variables, adjusted for age, sex, and BMI or height and
weight, in order to confirm relevant correlated variables. The
same model was replicated with hand ESC as the dependent
variable. All statistical analyses were performed with R
version 2.13.1 software.22
Table 1. Body Mass Index and Hand and Foot Electrochemical Skin Conductances by Gender
and Age Deciles in a Large Population of Healthy White Subjects (the Primary Cohort)
Gender, characteristic Overall
Age decile (years)
21–30 31–40 41–50 51–60 61–70 71–80
Female (n) 455 29 73 136 143 28 46
Age (mean – SD) (years) 50.0 – 12.5 26.7 – 2.7 36.4 – 2.7 45.8 – 2.8 55.3 – 2.8 62.2 – 1.6 74.7 – 1.3
BMI (mean – SD) (kg/m2) 22.4 – 1.7 21.5 – 2.0 22.2 – 1.6 22.6 – 1.5 22.6 – 1.7 22.6 – 1.5 22.1 – 1.9
ESC (lS)
Hands
Mean – SD 73.7 – 9.1 74.7 – 9.6 75.9 – 8.8 74.0 – 8.4 73.8 – 8.3 71.1 – 10.1 70.4 – 11.5
Median 75.0 75.0 77.0 74.5 75.0 70.3 73.5
5th–95th percentile interval 57.0–87.0 55.5–87.5 58.5–89.0 60.5–86.5 59.5–86.5 57.5–86.5 51.0–83.0
Feet
Mean – SD 82.4 – 6.3 83.9 – 5.8 84.2 – 4.8 83.1 – 5.2 82.7 – 5.6 82.2 – 4.2 76.0 – 9.9
Median 83.5 84.5 85.0 84.5 83.0 83.0 79.0
5th–95th percentile interval 71.0–90.0 68.5–91.0 76.5–91.0 74.5–91.0 72.0–90.0 76.0–88.0 54.5–87.5
Male (n) 202 46 30 33 42 10 41
Age (mean – SD) (years) 48.2 – 17.8 25.2 – 3.2 35.7 – 3.4 45.6 – 2.9 55.0 – 3.0 64.3 – 3.3 74.5 – 1.2
BMI (mean – SD) (kg/m2) 22.8 – 1.7 22.5 – 1.9 22.7 – 1.9 23.0 – 1.4 22.6 – 1.4 22.6 – 1.5 22.9 – 1.8
ESC (lS)
Hands
Mean – SD 74.5 – 9.7 76.0 – 10.1 77.4 – 6.6 75.2 – 10.7 75.8 – 7.7 72.3 – 11.6 69.3 – 10.2
Median 76.0 77.5 78.3 78.0 76.3 75.0 72.0
5th–95th percentile interval 56.0–88.5 56.0–90.0 64.0–88.0 56.0–89.5 62.5–87.5 52.0–86.5 52.0–81.0
Feet
Mean – SD 81.5 – 6.9 81.7 – 7.6 81.2 – 5.6 81.0 – 7.1 84.0 – 5.7 81.5 – 4.4 76.6 – 7.9
Median 82.5 82.5 81.0 83.0 84.5 81.8 81.5
5th–95th percentile interval 70.0–90.5 72.5–91.0 71.0–89.5 68.5–91.0 75.0–90.0 73.5–88.0 68.0–88.5
BMI, body mass index; ESC, electrochemical skin conductance.
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Results
The measurement of ESC was completed in all subjects
without incident: none of the 1,350 participants experienced
any discomfort, and there were no adverse events, compli-
cations, or safety concerns.
For the 570 subjects in the Primary Cohort (excluding
participants older than 70 years), mean age was 45.6 – 11.2
years, and median (5th–95th percentile intervals) ESC was 76
(62–86) lS for hands and 83 (75–89) lS for feet. Coefficient
of correlation between the right and left side in this popula-
tion was r = 0.96, P < 0.0001 for ESC of hands and r= 0.97,
P < 0.0001 for ESC of feet (Fig. 1). The reproducibility of
ESC measurement between two devices used sequentially in
the same encounter was established in previous studies
(r = 0.85 for hands and 0.93 for feet, P < 0.001).23
Hands and feet ESC values according to gender and age
deciles in the Primary Cohort are given in Table 1. No dif-
ference was observed between women and men for hands (75
[57–87] vs. 76 [56–89] lS; P = 0.35) and feet ESC (83.5 [71–
90] vs. 82.5 [70–91] lS; P= 0.12). A weak but significant
negative correlation between ESC and age was found for the
hands (r=-0.17, P< 0.0001) and for the feet (r=-0.19,
P< 0.0001) in this population (Fig. 2). No significant corre-
lation between BMI and hands or feet conductance was de-
tected (r= 0.01, P= 0.84 and r=-0.02, P= 0.65, respectively).
Multivariate analysis using age, sex, and BMI or height and
weight demonstrated that only age remained significantly
correlated with hands and feet ESC values: -0.11 (-0.16,
-0.06) lS per year for hands ESC and -0.09 (-0.12, -0.05) lS
per year for feet ESC (by Student’s t test, P< 0.0001 for both).
Among a subgroup of 244 participants of the Primary
Cohort with normoglycemia (hemoglobin A1c <6% or fast-
ing plasma glucose <6mmol/L), median hands (72.5 [54.0–
82.5] lS) and feet (83.0 [68.5–89] lS) ESC values were not
significantly different from those of the entire cohort. Among
26 participants of the Primary Cohort (mean age, 45 – 8
years), the median (5th–95th percentile interval) difference
between measurements performed before and after exercise
was 0.5 (-3.5, 9.5) lS for feet ESC (by Wilcoxon test,
P = 0.2544) and 9.2 (1.5, 35.5) lS for hands ESC (by Wil-
coxon test, P < 0.0001).
Table 2 presents ESC and demographics of the entire study
population except for whites >70 years of age. Each column
represents a unique clinical site except Columns B (n = 26
whites) and G (n= 24 African Americans) in Norfolk, VA, as
well as Columns E (n = 73 whites) and H (n= 93 African
Americans) in Winston-Salem, NC. Among subgroups of
whites with documented assessment of the peripheral nervous
system or renal function, or of Mexican ethnicity, hands and
feet ESCwere comparable to values observed in the less well-
characterized Primary Cohort (Table 2). Significantly lower
hands and feet ESC were observed for African American,
Indian, and Chinese populations compared with the white
population (Table 2, P< 0.0001 for means of hands or feet
ESC). Correlation with age and absence of significant cor-
relation with BMI were confirmed in these populations,
similar to the Primary Cohort.
Discussion
Assessment of skin chloride ion transport as ESC, a pu-
tative sweat surrogate measurement obtained using a non-
invasive, rapid, objective, and quantitative technique, has
emerged as a useful tool for the study of peripheral neurop-
athy.7,9,11 This analysis performed on 1,350 healthy partici-
pants enrolled in clinical trial centers constitutes a large
population compared with published normative data for other
methods of peripheral nerve function measurement. The in-
clusion of participants with different ethnicities, sex, weight,
BMI, and height provides reference values for ESC across a
wide spectrum of conditions that could broaden its clinical use.
There is excellent symmetry between right- and left-sided
measures of ESC, without differences related to gender or
BMI, but with a slight decrease in ESC with age. Finally,
significantly lower normal values for ESC were observed in
African American, Indian, and Chinese groups relative to
whites; validation of this finding is warranted in larger studies.
ESC is a measure of small-diameter peripheral nerve
function. Other small fiber functional measures include the
FIG. 2. Evolution of (a) hand and (b) foot electrochemical
skin conductance (ESC) values with age. Straight lines are
5th, 50th, and 95th percentiles, respectively.
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quantitative sudomotor axon reflex test (QSART) and quan-
titative sensory testing for heat pain and temperature detection
thresholds.24,25 Three-millimeter punch skin biopsy for in-
traepidermal fiber nerve density (IENFD) and corneal con-
focal microscopy are structural measures of small nerve axon
integrity.12,24–26 The good correlation observed between the
right and left sides is in accordance with and possibly superior
to the symmetry between sides observed in QSART and in
skin biopsy.13,26
No sex difference in ESC was observed. This is in accord-
ance with the absence of sex effect generally observed in the
analysis of corneal small fibers through corneal confocal mi-
croscopy.12 In contrast, a sex effect was observed in many of
the reference small nerve fiber tests: IENFD is lower in healthy
men compared with women; QSART volumes are higher in
men compared with women, likely explained by men’s higher
sweat secretion per gland13,27; and women show higher cold
and heat pain sensitivity with quantitative sensory testing.28
Similar to results observedwith IENFDor corneal confocal
microscopy,12,26 BMI appeared to have no significant effect
on ESC results. A slight decrease with age was observed in
hands and feet ESC values. Different studies of IENFD and
corneal confocal microscopy have reported contradictory
results regarding the effect of age on these measures.12,29–33
Low et al.,13 using the QSART, found a decrease in sudo-
motor function with age more or less pronounced depending
on the site of measurement. The reduction of sweat function
with aging observed in QSART ismainly due to a lower sweat
output per sweat gland along with a less marked decrease in
the number of sweat glands.13 This concurs with studies
performed on mice that evidenced identical findings: reduced
sweating with age was mainly due to a lower sweat output per
sweat gland, with a less marked decrease in the number of
secreting sweat glands.34 This could explain the lesser rela-
tionship with age observed in hand and foot ESC values,
which are independent of sweat volumes, contrary to
QSART.13 Overall, measurement of ESC has higher between-
limb symmetry and age-related stability compared with other
measures of small fiber function.
An important effect of ethnicity on normal ESC was ob-
served. African American, Indian, and Chinese subjects had
mean hands and feet ESC values 10–15 lS lower than those
of whites. This difference was also observed between the
subgroups of whites and African Americans confirmed to
have normal peripheral nerve function during detailed as-
sessments. Few data on differences in sudomotor function
related to ethnicity are available, but a recent study has re-
ported that QSART volumes are smaller in Chinese sub-
jects.35 Whether differences in the inherent mechanisms of
sweating (i.e., ion transport or small nerve fibers) or other
factors are responsible for ESC ethnic variations remains to
be established. Furthermore, the small numbers of African
American and Asian subjects in this study do not allow for an
adequate population comparison with white subjects or es-
tablishment of normative ESC ranges for these ethnicities.
The limited variation observed in hands ESC between a
first measurement made at rest and a second measurement
performed just after exercise and the absence of variation in
feet ESC agrees with the reproducibility between two mea-
surements at rest observed in previous studies and with the
lack of effect of exercise on a population of more than 100
subjects, including some with higher BMI.15 These results
confirm that feet ESC could be used for large-scale screening
where the observance of a sufficient period of rest before
measurement cannot be ensured15 or for evaluation of auto-
nomic function change in lifestyle intervention studies.
Tests of sudomotor function are recognized as valuable in
the evaluation of peripheral small fiber neuropathies, but their
clinical and research use has been restricted by test complex-
ity, lack of access, or limited accuracy and reproducibility.
Table 3, comparing the reported performance of sudomotor
tests, indicates that simple ESC measurements perform very
competitively against validated sudomotor standards.
This study has limitations: (1) The absence of peripheral
neuropathy was not confirmed by a complete neurological
clinical examination in the Primary Cohort, although it
was performed in smaller subsets of white and African
American subjects.7–9,11 (2) ESC measurements were carried
out by different investigators using different devices. How-
ever, the hardware, stimulus intensity, and software algo-
rithm are identical, the measurement is objective and not
operator-dependent, and the reproducibility between two
devices has been tested previously.23 (3) Although only data
from healthy participants were used in this analysis, different
testing centers selected participants using different criteria.
Regardless, mean and median ESC results were relatively
comparable across studies. (4) Some age and ethnic groups
are underrepresented. Normative data for children are not
Table 3. Sudomotor Testing Performance for Evaluation of Distal Small Fiber Dysfunction
Test Reproducibility
Small fiber dysfunction
Sensitivity Specificity
Thermoregulatory sweat testing High reproducibility36 72–74% (distal anhydrosis) High
Sympathetic skin response CV for latency = 9–16%; CV for
amplitude = 13–30%37
Low–moderate36,38 Not available
Quantitative sudomotor axon
reflex test
ICC foot= 0.48–0.5239,40 74–90%41,42 >90%41
ESC (Sudoscan) Feet ESC CC= 0.93, hands ESC
CC= 0.85 between two devices
75–80%43 76.2–100%7,11,43
Sweat gland nerve fiber density Inter-rater variability = 10.2 – 8.4%a Not available Not available
Neuropad CV = 4.1–5.1%44 52–97.8%45–47 66–96%48
aInternal laboratory quality assurance data on file at Therapathcommunicated to the authors.
CC, correlation coefficient; CV, coefficient of variation; ESC, electrochemical skin conductance; ICC, intraclass correlation coefficient.
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examined in this study, and larger studies in different ethnic
groups are necessary to define normative values for these
subgroups. (5) Finally, additional comparisons among IENF
structure, sweating per se, and ESC measurements are nec-
essary to establish correlations between the structure and
function of sweat glands and the peripheral nervous system as
a whole. Such information would augment the value of this
simple, rapid, and highly reproducible and stable test (1) in
the diagnosis and management of patients with peripheral
nerve damage, (2) for use as a screening tool, and (3) as an
end point in clinical trials in neuropathy.
In conclusion, this analysis performed on 1,350 healthy
subjects demonstrates that factors influencing ESC mea-
surements include ethnicity and, to a lesser extent, age, which
compares favorably with more invasive or technically com-
plex reference methods for identification and evaluation of
neuropathy. The normative ranges presented here should help
to interpret ESC results and to enhance the value of their
measurement when evaluating peripheral nerve fiber func-
tion. Further work is required to validate the measurements
among all ethnic groups.
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